Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
Abstract NTRK gene fusions are rare somatic mutations found across cancer types with promising targeted therapies emerging. Healthcare systems face significant challenges in integrating these treatments, with uncertainty in prevalence and optimal testing methods to identify eligible patients. We per...
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Nature Portfolio
2023-03-01
|
| Sarja: | Scientific Reports |
| Linkit: | https://doi.org/10.1038/s41598-023-31055-3 |